BioSpace News Archive

BioMidwest

Abbott Launches World’s First Pivotal Trial to Test New Approach for Repairing Leaky Tricuspid Heart Valves

TRILUMINATE Pivotal trial is the world’s first randomized clinical trial to evaluate transcatheter tricuspid valve repair in patients with severe tricuspid regurgitation

September 5, 2019
·
5 min read
Pharm Country

Muscular Dystrophy Association Awards 25 Grants Totaling More Than $6.6 Million for Neuromuscular Disease Research

The Muscular Dystrophy Association (MDA) announced today the awarding of 25 new MDA grants totaling more than $6.6 million toward research focused on a variety of neuromuscular diseases (NMDs)

September 5, 2019
·
9 min read
Business

Polytex Technologies Receives Major Investment from Fortissimo Capital and Appoints New CEO

Polytex Technologies is pleased to announce it has received a major investment by private equity fund Fortissimo Capital, and welcomes its newly appointed CEO, Yariv Matzliach.

September 5, 2019
·
2 min read
Business

AsOne Healthcare IPA and Netsmart Partner to Utilize Care Coordination and Data to Enable Success in a Value-Based Payment Environment

Netsmart and AsOne Healthcare Independent Practice Association (AsOne) announced their partnership to utilize the Netsmart population health management platform and services to coordinate care delivery and improve outcomes for the individuals they serve

September 5, 2019
·
6 min read
Terramera Raises US$45 Million to Reduce Synthetic Chemicals in Agriculture by 80%

Company adds veteran leader Carl Casale; set to transform agriculture and achieve 2030 goal of reducing global synthetic chemical loads in agriculture by 80%

September 5, 2019
·
4 min read
Drug Development

Usona Institute Clinical Trial of Psilocybin for Major Depressive Disorder Launching This Fall

Usona Institute launches its Phase 2 study of psilocybin for major depressive disorder this fall.

September 5, 2019
·
2 min read
Deals

TransEnterix Announces Pricing of Public Offering of Common Stock

TransEnterix, Inc. announced that it priced a public offering of 28,000,000 shares of its common stock for gross proceeds of approximately $20.3 million, before deducting underwriting discounts and commissions and offering expenses payable by TransEnterix.

September 5, 2019
·
3 min read
BioMidwest

Invacare Corporation Provides Business Update at Baird Global Healthcare Conference

Company Reaffirms Full-Year 2019 and 2020 Guidance

September 5, 2019
·
5 min read
FDA

Amneal Announces Approval of Generic Version of Amicar®

Amneal Pharmaceuticals, Inc. (NYSE: AMRX), today announced that it has received approval from the U.S. Food and Drug Administration (FDA) for its generic version of Amicar® (aminocaproic acid oral solution) 0.25g/mL.

September 5, 2019
·
5 min read
Business

Ten Tips to Help After a Prostate Cancer Diagnosis or Prostate Surgery

Men’s Liberty™ is sharing the top tips from their users after a prostate cancer diagnosis and their preferred solution to help men regain their freedom from urinary incontinence after prostate surgery

September 5, 2019
·
2 min read